{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:40:24Z","timestamp":1787992824489,"version":"build-2784847793"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11892-025-01590-6","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:42:01Z","timestamp":1752554521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["From Type 2 Diabetes Mellitus To Diabetic Cardiomyopathy \u2013 A Systematic Review On The Role Of MicroRNA"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1791-4661","authenticated-orcid":false,"given":"Anna","family":"\u017barek-Starzewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8825-511X","authenticated-orcid":false,"given":"Dominika","family":"Klimczak-Tomaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"M\u0105drecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Sygitowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Janiszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"1","key":"1590_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107\u201311. https:\/\/doi.org\/10.2991\/jegh.k.191028.001.","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"1590_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ecl.2021.05.013","volume":"50","author":"MG Tinajero","year":"2021","unstructured":"Tinajero MG, Malik VS. An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. Endocrinol Metab Clin North Am. 2021;50(3):337\u201355. https:\/\/doi.org\/10.1016\/j.ecl.2021.05.013.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"13","key":"1590_CR3","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246\u201358. https:\/\/doi.org\/10.4239\/wjd.v6.i13.1246.","journal-title":"World J Diabetes"},{"issue":"19","key":"1590_CR4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"issue":"8","key":"1590_CR5","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879\u201384. https:\/\/doi.org\/10.2337\/diacare.27.8.1879.","journal-title":"Diabetes Care"},{"issue":"1","key":"1590_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ejhf.455","volume":"18","author":"DH Elder","year":"2016","unstructured":"Elder DH, Singh JS, Levin D, et al. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study. Eur J Heart Fail. 2016;18(1):94\u2013102. https:\/\/doi.org\/10.1002\/ejhf.455.","journal-title":"Eur J Heart Fail"},{"key":"1590_CR7","doi-asserted-by":"publisher","unstructured":"Task Force Members et al. \u201cESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).\u201dEuropean heart journal\u201d 2013; 34(39): 3035\u201387. https:\/\/doi.org\/10.1093\/eurheartj\/eht108","DOI":"10.1093\/eurheartj\/eht108"},{"issue":"1","key":"1590_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","volume":"124","author":"HC Kenny","year":"2019","unstructured":"Kenny HC, Abel ED. Heart Failure in Type 2 Diabetes Mellitus. Circ Res. 2019;124(1):121\u201341. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.311371.","journal-title":"Circ Res"},{"key":"1590_CR9","doi-asserted-by":"publisher","unstructured":"Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L; ESC-HFA HF Long-Term Registry investigators. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(1):54\u201365. https:\/\/doi.org\/10.1002\/ejhf.679","DOI":"10.1002\/ejhf.679"},{"issue":"1","key":"1590_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","volume":"16","author":"A Lorenzo-Almor\u00f3s","year":"2017","unstructured":"Lorenzo-Almor\u00f3s A, Tu\u00f1\u00f3n J, Orejas M, Cort\u00e9s M, Egido J, Lorenzo \u00d3. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017;16(1):28. https:\/\/doi.org\/10.1186\/s12933-017-0506-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1590_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18(2):149\u201366. https:\/\/doi.org\/10.1007\/s10741-012-9313-3.","journal-title":"Heart Fail Rev"},{"key":"1590_CR12","doi-asserted-by":"publisher","first-page":"841928","DOI":"10.3389\/fcvm.2022.841928","volume":"9","author":"H Wu","year":"2022","unstructured":"Wu H, Norton V, Cui K, et al. Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses. Front Cardiovasc Med. 2022;9:841928. https:\/\/doi.org\/10.3389\/fcvm.2022.841928.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1590_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010;11(1):31\u20139. https:\/\/doi.org\/10.1007\/s11154-010-9131-7.","journal-title":"Rev Endocr Metab Disord"},{"issue":"8","key":"1590_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00592-021-01705-x","volume":"58","author":"R Marfella","year":"2021","unstructured":"Marfella R, Sardu C, Mansueto G, Napoli C, Paolisso G. Evidence for human diabetic cardiomyopathy. Acta Diabetol. 2021;58(8):983\u20138. https:\/\/doi.org\/10.1007\/s00592-021-01705-x.","journal-title":"Acta Diabetol"},{"issue":"4","key":"1590_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res. 2018;122(4):624\u201338. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586.","journal-title":"Circ Res"},{"issue":"6","key":"1590_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/CS20040057","volume":"107","author":"SA Hayat","year":"2004","unstructured":"Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004;107(6):539\u201357. https:\/\/doi.org\/10.1042\/CS20040057.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1590_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/diacare.24.1.5","volume":"24","author":"P Poirier","year":"2001","unstructured":"Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24(1):5\u201310. https:\/\/doi.org\/10.2337\/diacare.24.1.5.","journal-title":"Diabetes Care"},{"issue":"9","key":"1590_CR18","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/eurjhf\/hfq110","volume":"12","author":"S Kiencke","year":"2010","unstructured":"Kiencke S, Handschin R, von Dahlen R, et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail. 2010;12(9):951\u20137. https:\/\/doi.org\/10.1093\/eurjhf\/hfq110.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"1590_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660\u201371. https:\/\/doi.org\/10.1007\/s00125-014-3171-6.","journal-title":"Diabetologia"},{"issue":"1","key":"1590_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s42003-022-03987-5","volume":"5","author":"MJ Donde","year":"2022","unstructured":"Donde MJ, Rochussen AM, Kapoor S, Taylor AI. Targeting non-coding RNA family members with artificial endonuclease XNAzymes. Commun Biol. 2022;5(1):1010. https:\/\/doi.org\/10.1038\/s42003-022-03987-5.","journal-title":"Commun Biol"},{"issue":"1","key":"1590_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.20452\/pamw.15137","volume":"130","author":"G Sygitowicz","year":"2020","unstructured":"Sygitowicz G, Maciejak-Jastrz\u0119bska A, Sitkiewicz D. MicroRNAs in the development of left ventricular remodeling and postmyocardial infarction heart failure. Pol Arch Intern Med. 2020;130(1):59\u201365. https:\/\/doi.org\/10.20452\/pamw.15137.","journal-title":"Pol Arch Intern Med"},{"key":"1590_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fgene.2014.00185","volume":"5","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Lv D, Chen P, Xu T, Fu S, Li J, Bei Y. MicroRNAs in diabetic cardiomyopathy and clinical perspectives. Front Genet. 2014;5:185. https:\/\/doi.org\/10.3389\/fgene.2014.00185.","journal-title":"Front Genet"},{"issue":"8","key":"1590_CR23","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","volume":"1863","author":"R Guo","year":"2017","unstructured":"Guo R, Nair S. Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):2070\u20137. https:\/\/doi.org\/10.1016\/j.bbadis.2017.03.013.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"1590_CR24","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1038\/s41598-017-13875-2","volume":"7","author":"CU Copier","year":"2017","unstructured":"Copier CU, Le\u00f3n L, Fern\u00e1ndez M, Contador D, Calligaris SD. Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy. Sci Rep. 2017;7(1):13514. https:\/\/doi.org\/10.1038\/s41598-017-13875-2.","journal-title":"Sci Rep"},{"key":"1590_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12933-024-02252-9","volume":"23","author":"X Yao","year":"2024","unstructured":"Yao X, Huang X, Chen J, et al. Roles of non-coding RNA in diabetic cardiomyopathy. Cardiovasc Diabetol. 2024;23:227. https:\/\/doi.org\/10.1186\/s12933-024-02252-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1590_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/0118715257265947231129074526","volume":"22","author":"P Mathur","year":"2024","unstructured":"Mathur P, Saxena S, Saxena B, Rani V. MicroRNAs Targeting Critical Molecular Pathways in Diabetic Cardiomyopathy Emerging Valuable for Therapy. Cardiovasc Hematol Agents Med Chem. 2024;22(3):298\u2013307. https:\/\/doi.org\/10.2174\/0118715257265947231129074526.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"1590_CR27","doi-asserted-by":"publisher","first-page":"1124613","DOI":"10.3389\/fendo.2023.1124613","volume":"14","author":"MT Macvanin","year":"2023","unstructured":"Macvanin MT, Gluvic Z, Radovanovic J, Essack M, Gao X, Isenovic ER. Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs. Front Endocrinol (Lausanne). 2023;14:1124613. https:\/\/doi.org\/10.3389\/fendo.2023.1124613.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1590_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","volume":"20","author":"D Jakubik","year":"2021","unstructured":"Jakubik D, Fitas A, Eyileten C, et al. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol. 2021;20(1):55. https:\/\/doi.org\/10.1186\/s12933-021-01245-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1590_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4.","journal-title":"Syst Rev"},{"issue":"1","key":"1590_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2\u201310. https:\/\/doi.org\/10.1111\/jebm.12141.","journal-title":"J Evid Based Med"},{"key":"1590_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12874-021-01295-w","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Tam DNH, Elshafay A, et al. Quality assessment tools used in systematic reviews of in vitro studies: A systematic review. BMC Med Res Methodol. 2021;21:101. https:\/\/doi.org\/10.1186\/s12874-021-01295-w.","journal-title":"BMC Med Res Methodol"},{"key":"1590_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"1590_CR33","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED. Basic Mechanisms of Diabetic Heart Disease. Circ Res. 2020;126(11):1501\u201325. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315913.","journal-title":"Circ Res"},{"key":"1590_CR34","doi-asserted-by":"publisher","unstructured":"Xu CR, Fang QJ. Inhibiting Glucose Metabolism By miR-34a and miR-125b Protects Against Hyperglycemia-Induced Cardiomyocyte Cell Death. A Inibi\u00e7\u00e3o do Metabolismo da Glicose por miR-34a e miR-125b Protege contra a Morte Celular de Cardiomi\u00f3citos Causada por Hiperglicemia. Arq Bras Cardiol. 2021;116(3):415\u2013422. https:\/\/doi.org\/10.36660\/abc.20190529","DOI":"10.36660\/abc.20190529"},{"issue":"1\u20132","key":"1590_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","volume":"417","author":"SK Raut","year":"2016","unstructured":"Raut SK, Singh GB, Rastogi B, et al. miR-30c and miR-181a synergistically modulate p53\u2013p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem. 2016;417(1\u20132):191\u2013203. https:\/\/doi.org\/10.1007\/s11010-016-2729-7.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1590_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s11658-022-00379-9","volume":"27","author":"M Yu","year":"2022","unstructured":"Yu M, Sun Y, Shan X, Yang F, Chu G, Chen Q, Han L, Guo Z, Wang G. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy. Cell Mol Biol Lett. 2022;27(1):85. https:\/\/doi.org\/10.1186\/s11658-022-00379-9.","journal-title":"Cell Mol Biol Lett"},{"key":"1590_CR37","doi-asserted-by":"publisher","unstructured":"Tang Q, Len Q, Liu Z, Wang W. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1. Cardiovasc Ther. 2018;36(2):https:\/\/doi.org\/10.1111\/1755-5922.12318","DOI":"10.1111\/1755-5922.12318"},{"key":"1590_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5604\/01.3001.0014.5247","volume":"74","author":"G Sygitowicz","year":"2020","unstructured":"Sygitowicz G, Sitkiewicz D. Sirtuins and their role as physiological modulators of metabolism. Adv Hygiene Experimental Med. 2020;74:489\u201397. https:\/\/doi.org\/10.5604\/01.3001.0014.5247.","journal-title":"Adv Hygiene Experimental Med"},{"issue":"6","key":"1590_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.carpath.2015.06.003","volume":"24","author":"M Yu","year":"2015","unstructured":"Yu M, Liu Y, Zhang B, Shi Y, Cui L, Zhao X. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Cardiovasc Pathol. 2015;24(6):375\u201381. https:\/\/doi.org\/10.1016\/j.carpath.2015.06.003.","journal-title":"Cardiovasc Pathol"},{"key":"1590_CR40","doi-asserted-by":"publisher","unstructured":"Tao L, Huang X, Xu M, Yang L, Hua F. MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis [published correction appears in FASEB J. 2021;35(12):e22064. https:\/\/doi.org\/10.1096\/fsb2.22064]. FASEB J. 2020;34(2):2173\u20132197. https:\/\/doi.org\/10.1096\/fj.201901838R","DOI":"10.1096\/fsb2.22064"},{"key":"1590_CR41","doi-asserted-by":"publisher","first-page":"110944","DOI":"10.1016\/j.mce.2020.110944","volume":"518","author":"L Tao","year":"2020","unstructured":"Tao L, Huang X, Xu M, Qin Z, Zhang F, Hua F, Jiang X, Wang Y. Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy. Mol Cell Endocrinol. 2020;518:110944. https:\/\/doi.org\/10.1016\/j.mce.2020.110944.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1590_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0811-7","volume":"18","author":"Z Yin","year":"2019","unstructured":"Yin Z, Zhao Y, He M, Li H, Fan J, Nie X, Yan M, Chen C, Wang DW. MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1. Cardiovasc Diabetol. 2019;18(1):7. https:\/\/doi.org\/10.1186\/s12933-019-0811-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"1590_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/cells11050844","volume":"11","author":"K Lipke","year":"2022","unstructured":"Lipke K, Kubis-Kubiak A, Piwowar A. Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States-Current View of Knowledge. Cells. 2022;11(5):844. https:\/\/doi.org\/10.3390\/cells11050844.","journal-title":"Cells"},{"issue":"4","key":"1590_CR44","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1002\/jcb.27795","volume":"120","author":"L Xu","year":"2019","unstructured":"Xu L, Chen W, Ma M, et al. Microarray profiling analysis identifies the mechanism of miR-200b-3p\/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-\u03b3 signalling pathway. J Cell Biochem. 2019;120(4):5193\u2013206. https:\/\/doi.org\/10.1002\/jcb.27795.","journal-title":"J Cell Biochem"},{"issue":"12","key":"1590_CR45","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.119.314898","volume":"125","author":"H Li","year":"2019","unstructured":"Li H, Fan J, Zhao Y, et al. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart. Circ Res. 2019;125(12):1106\u201320. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.314898.","journal-title":"Circ Res"},{"issue":"1","key":"1590_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvw235","volume":"113","author":"S Rawal","year":"2017","unstructured":"Rawal S, Munasinghe PE, Shindikar A, et al. Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovasc Res. 2017;113(1):90\u2013101. https:\/\/doi.org\/10.1093\/cvr\/cvw235.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1590_CR47","doi-asserted-by":"publisher","first-page":"9532","DOI":"10.1002\/jcb.28229","volume":"120","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zheng W, Pan Y, Hu J. Low expression of miR-186-5p regulates cell apoptosis by targeting toll-like receptor 3 in high glucose-induced cardiomyocytes. J Cell Biochem. 2019;120(6):9532\u20138. https:\/\/doi.org\/10.1002\/jcb.28229.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1590_CR48","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3892\/etm.2017.5445","volume":"15","author":"J Jiang","year":"2018","unstructured":"Jiang J, Mo H, Liu C, et al. Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes. Exp Ther Med. 2018;15(1):627\u201332. https:\/\/doi.org\/10.3892\/etm.2017.5445.","journal-title":"Exp Ther Med"},{"issue":"6","key":"1590_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jb\/mvac025","volume":"171","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Z, Wang M. MiR-29a regulates cardiomyocyte apoptosis by targeting Bak1 in diabetic cardiomyopathy. J Biochem. 2022;171(6):663\u201371. https:\/\/doi.org\/10.1093\/jb\/mvac025.","journal-title":"J Biochem"},{"issue":"1","key":"1590_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4093\/dmj.2018.0211","volume":"44","author":"IH Park","year":"2020","unstructured":"Park IH, Song YS, Joo HW, et al. Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic Cardiomyopathy. Diabetes Metab J. 2020;44(1):173\u201385. https:\/\/doi.org\/10.4093\/dmj.2018.0211.","journal-title":"Diabetes Metab J"},{"issue":"7","key":"1590_CR51","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41418-017-0047-6","volume":"25","author":"I Fomison-Nurse","year":"2018","unstructured":"Fomison-Nurse I, Saw EEL, Gandhi S, Munasinghe PE, Van Hout I, Williams MJA, Galvin I, Bunton R, Davis P, Cameron V, Katare R. Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells. Cell Death Differ. 2018;25(7):1336\u201349. https:\/\/doi.org\/10.1038\/s41418-017-0047-6.","journal-title":"Cell Death Differ"},{"key":"1590_CR52","doi-asserted-by":"publisher","first-page":"101558","DOI":"10.1016\/j.mcp.2020.101558","volume":"52","author":"X Xia","year":"2020","unstructured":"Xia X, Liang Y, Zheng W, Lin D, Sun S. miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis. Mol Cell Probes. 2020;52:101558. https:\/\/doi.org\/10.1016\/j.mcp.2020.101558.","journal-title":"Mol Cell Probes"},{"key":"1590_CR53","doi-asserted-by":"publisher","first-page":"117980","DOI":"10.1016\/j.lfs.2020.117980","volume":"256","author":"D Xu","year":"2020","unstructured":"Xu D, Zhang X, Chen X, Yang S, Chen H. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy. Life Sci. 2020;256:117980. https:\/\/doi.org\/10.1016\/j.lfs.2020.117980.","journal-title":"Life Sci"},{"issue":"4","key":"1590_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.bbrc.2016.06.051","volume":"477","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, Zhao Y, Liu Y, Ma N, Wang C, Zou J, Liu Z, Zhou Z, Han D, He J, Sun Q, Liu Y, Xu C, Du Z, Huang H. miR-483-3p regulates hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice. Biochem Biophys Res Commun. 2016;477(4):541\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2016.06.051.","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"1590_CR55","doi-asserted-by":"publisher","first-page":"14129","DOI":"10.3390\/ijms232214129","volume":"23","author":"G Sygitowicz","year":"2022","unstructured":"Sygitowicz G, Sitkiewicz D. Involvement of circRNAs in the Development of Heart Failure. Int J Mol Sci. 2022;23(22):14129. https:\/\/doi.org\/10.3390\/ijms232214129.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1590_CR56","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/mmr.2020.11248","volume":"22","author":"S Dong","year":"2020","unstructured":"Dong S, Tu C, Ye X, Li L, Zhang M, Xue A, Chen S, Zhao Z, Cong B, Lin J, Shen Y. Expression profiling of circular RNAs and their potential role in early-stage diabetic cardiomyopathy. Mol Med Rep. 2020;22(3):1958\u201368. https:\/\/doi.org\/10.3892\/mmr.2020.11248.","journal-title":"Mol Med Rep"},{"key":"1590_CR57","doi-asserted-by":"publisher","first-page":"3182931","DOI":"10.1155\/2022\/3182931","volume":"2022","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yang X, Zhou J, Chen L, Zuo P, Chen L, Jiang L, Li T, Wang D, Xu Y, Li Q, Yan Y. miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1. Oxid Med Cell Longev. 2022;2022:3182931. https:\/\/doi.org\/10.1155\/2022\/3182931.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1590_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2019.09.092","volume":"520","author":"R Xing","year":"2019","unstructured":"Xing R, Liu D, Cheng X, Tian X, Yan C, Han Y. MiR-207 inhibits autophagy and promotes apoptosis of cardiomyocytes by directly targeting LAMP2 in type 2 diabetic cardiomyopathy. Biochem Biophys Res Commun. 2019;520(1):27\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.092.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1590_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1139\/bcb-2017-0154","volume":"96","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Zhang D, Zhu M, Wang Y, Guo S, Xu B, Hou G, Feng Y, Liu G. Liver X receptor \u03b1 is targeted by microRNA-1 to inhibit cardiomyocyte apoptosis through a ROS-mediated mitochondrial pathway. Biochem Cell Biol. 2018;96(1):11\u20138. https:\/\/doi.org\/10.1139\/bcb-2017-0154.","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"1590_CR60","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3892\/etm.2018.6388","volume":"16","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Zhao W, Zhang X, Sun L, Yang H, Wang Y, Cao Y, Chu Y, Liu G. Downregulation of microRNA-1 attenuates glucose-induced apoptosis by regulating the liver X receptor \u03b1 in cardiomyocytes. Exp Ther Med. 2018;16(3):1814\u201324. https:\/\/doi.org\/10.3892\/etm.2018.6388.","journal-title":"Exp Ther Med"},{"issue":"3","key":"1590_CR61","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00125-015-3827-x","volume":"59","author":"MV Cannon","year":"2016","unstructured":"Cannon MV, Sillj\u00e9 HHW, Sijbesma JWA, Khan MAF, Steffensen KR, van Gilst WH, de Boer RA. LXR\u03b1 improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes. Diabetologia. 2016;59(3):634\u201343. https:\/\/doi.org\/10.1007\/s00125-015-3827-x.","journal-title":"Diabetologia"},{"key":"1590_CR62","doi-asserted-by":"publisher","first-page":"9167450","DOI":"10.1155\/2017\/9167450","volume":"2017","author":"Y Miao","year":"2017","unstructured":"Miao Y, Wan Q, Liu X, Wang Y, Luo Y, Liu D, Lin N, Zhou H, Zhong J. miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2\/ARE Signaling Pathway. Biomed Res Int. 2017;2017:9167450. https:\/\/doi.org\/10.1155\/2017\/9167450.","journal-title":"Biomed Res Int"},{"key":"1590_CR63","doi-asserted-by":"publisher","first-page":"e2669","DOI":"10.6061\/clinics\/2021\/e2669","volume":"76","author":"W Qin","year":"2021","unstructured":"Qin W, Zhao X, Tai J, Qin G, Yu S. Combination of Dendrobium Mixture and Metformin Curbs the Development and Progression of Diabetic Cardiomyopathy by Targeting the lncRNA NEAT1. Clinics (Sao Paulo). 2021;76:e2669. https:\/\/doi.org\/10.6061\/clinics\/2021\/e2669.","journal-title":"Clinics (Sao Paulo)"},{"issue":"2","key":"1590_CR64","first-page":"142","volume":"13","author":"Y Song","year":"2020","unstructured":"Song Y, Mai H, Lin Y, Wang Y, Wang X, Gu S. MiR-144 affects proliferation and apoptosis of high glucose-induced AC16 cardiomyocytes by regulating CTRP3\/JNK signaling. Int J Clin Exp Pathol. 2020;13(2):142\u201352.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"1590_CR65","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"2","key":"1590_CR66","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Chen X, Zhou W, Men H, Bao T, Sun Y, Wang Q, Tan Y, Keller BB, Tong Q, Zheng Y, Cai L. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways. Acta Pharm Sin B. 2022;12(2):708\u201322. https:\/\/doi.org\/10.1016\/j.apsb.2021.10.005.","journal-title":"Acta Pharm Sin B"},{"issue":"21","key":"1590_CR67","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1111\/jcmm.16890","volume":"25","author":"T Ni","year":"2021","unstructured":"Ni T, Huang X, Pan S, Lu Z. Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J Cell Mol Med. 2021;25(21):9995\u201310007. https:\/\/doi.org\/10.1111\/jcmm.16890.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"1590_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99\u2013109. https:\/\/doi.org\/10.1038\/nrmicro2070.","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"1590_CR69","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ni.1960","volume":"11","author":"EA Miao","year":"2010","unstructured":"Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010;11(12):1136\u201342. https:\/\/doi.org\/10.1038\/ni.1960.","journal-title":"Nat Immunol"},{"issue":"10","key":"1590_CR70","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Qin Y, Lv J, Wang Y, Che H, Chen X, Jiang Y, Li A, Sun X, Yue E, Ren L, Li Y, Bai Y, Wang L. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018;9(10):1000. https:\/\/doi.org\/10.1038\/s41419-018-1029-4.","journal-title":"Cell Death Dis"},{"key":"1590_CR71","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.omtn.2019.06.026","volume":"17","author":"F Yang","year":"2019","unstructured":"Yang F, Li A, Qin Y, Che H, Wang Y, Lv J, Li Y, Li H, Yue E, Ding X, Yu Y, Bai Y, Wang L. A novel circular RNA mediates pyroptosis of diabetic cardiomyopathy by functioning as a competing endogenous RNA. Mol Ther Nucleic Acids. 2019;17:636\u201343. https:\/\/doi.org\/10.1016\/j.omtn.2019.06.026.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"1590_CR72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","volume":"471","author":"P Jeyabal","year":"2016","unstructured":"Jeyabal P, Thandavarayan RA, Joladarashi D, Suresh Babu S, Krishnamurthy S, Bhimaraj A, Youker KA, Kishore R, Krishnamurthy P. MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun. 2016;471(4):423\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.065.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"1590_CR73","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","volume":"5","author":"X Li","year":"2014","unstructured":"Li X, Du N, Zhang Q, Li J, Chen X, Liu X, Hu Y, Qin W, Shen N, Xu C, Fang Z, Wei Y, Wang R, Du Z, Zhang Y, Lu Y. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014;5(10):e1479. https:\/\/doi.org\/10.1038\/cddis.2014.430.","journal-title":"Cell Death Dis"},{"key":"1590_CR74","doi-asserted-by":"publisher","first-page":"153252","DOI":"10.1016\/j.tox.2022.153252","volume":"476","author":"S Zhao","year":"2022","unstructured":"Zhao S, Tan Y, Qin J, Xu H, Liu L, Wan H, Zhang C, Fan W, Qu S. MicroRNA-223\u20133p promotes pyroptosis of cardiomyocyte and release of inflammasome factors via downregulating the expression level of SPI1 (PU.1). Toxicology. 2022;476:153252. https:\/\/doi.org\/10.1016\/j.tox.2022.153252.","journal-title":"Toxicology"},{"issue":"4","key":"1590_CR75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3892\/mmr.2021.11898","volume":"23","author":"A Wu","year":"2021","unstructured":"Wu A, Sun W, Mou F. lncRNA-MALAT1 promotes high glucose-induced H9C2 cardiomyocyte pyroptosis by downregulating miR-141-3p expression. Mol Med Rep. 2021;23(4):259. https:\/\/doi.org\/10.3892\/mmr.2021.11898.","journal-title":"Mol Med Rep"},{"issue":"22","key":"1590_CR76","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1080\/15384101.2020.1831245","volume":"19","author":"Y Xu","year":"2020","unstructured":"Xu Y, Fang H, Xu Q, Xu C, Yang L, Huang C. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p\/AHR. Cell Cycle. 2020;19(22):3054\u201365. https:\/\/doi.org\/10.1080\/15384101.2020.1831245.","journal-title":"Cell Cycle"},{"issue":"2","key":"1590_CR77","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1080\/21655979.2021.2024688","volume":"13","author":"L Fu","year":"2022","unstructured":"Fu L, Zhang J, Lin Z, Li Y, Qin G. CircularRNA circ_0071269 knockdown protects against from diabetic cardiomyopathy injury by microRNA-145\/gasdermin A axis. Bioengineered. 2022;13(2):2398\u2013411. https:\/\/doi.org\/10.1080\/21655979.2021.2024688.","journal-title":"Bioengineered"},{"issue":"2","key":"1590_CR78","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2014.05.020","volume":"1852","author":"S Kobayashi","year":"2015","unstructured":"Kobayashi S, Liang Q. Autophagy and mitophagy in diabetic cardiomyopathy. Biochim Biophys Acta. 2015;1852(2):252\u201361. https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.020.","journal-title":"Biochim Biophys Acta"},{"key":"1590_CR79","doi-asserted-by":"publisher","first-page":"101338","DOI":"10.1016\/j.arr.2021.101338","volume":"68","author":"S Dewanjee","year":"2021","unstructured":"Dewanjee S, Vallamkondu J, Kalra RS, John A, Reddy PH, Kandimalla R. Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy. Ageing Res Rev. 2021;68:101338. https:\/\/doi.org\/10.1016\/j.arr.2021.101338.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1590_CR80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25\u201332. https:\/\/doi.org\/10.1172\/JCI73939.","journal-title":"J Clin Invest"},{"issue":"2","key":"1590_CR81","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ehf2.14311","volume":"10","author":"S Ning","year":"2023","unstructured":"Ning S, Zhang S, Guo Z. MicroRNA-494 regulates high glucose-induced cardiomyocyte apoptosis and autophagy by PI3K\/AKT\/mTOR signalling pathway. ESC Heart Fail. 2023;10(2):1401\u201311. https:\/\/doi.org\/10.1002\/ehf2.14311.","journal-title":"ESC Heart Fail"},{"issue":"3","key":"1590_CR82","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41419-020-2316-4","volume":"11","author":"QQ Wu","year":"2020","unstructured":"Wu QQ, Liu C, Cai Z, Xie Q, Hu T, Duan M, Wu H, Yuan Y, Tang Q. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition. Cell Death Dis. 2020;11(3):160. https:\/\/doi.org\/10.1038\/s41419-020-2316-4.","journal-title":"Cell Death Dis"},{"key":"1590_CR83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.omtn.2017.03.005","volume":"7","author":"C Chen","year":"2017","unstructured":"Chen C, Yang S, Li H, Yin Z, Fan J, Zhao Y, Gong W, Yan M, Wang DW. Mir30c is involved in diabetic cardiomyopathy through regulation of cardiac autophagy via BECN1. Mol Ther Nucleic Acids. 2017;7:127\u201339. https:\/\/doi.org\/10.1016\/j.omtn.2017.03.005.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"1590_CR84","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jcmm.12218","volume":"18","author":"S Chen","year":"2014","unstructured":"Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW 2nd, Chakrabarti S. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med. 2014;18(3):415\u201321. https:\/\/doi.org\/10.1111\/jcmm.12218.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"1590_CR85","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.26355\/eurrev_202006_2153","volume":"24","author":"WY Zhang","year":"2020","unstructured":"Zhang WY, Wang J, Li AZ. A study of the effects of SGLT-2 inhibitors on diabetic cardiomyopathy through miR-30d\/KLF9\/VEGFA pathway. Eur Rev Med Pharmacol Sci. 2020;24(11):6346\u201359. https:\/\/doi.org\/10.26355\/eurrev_202006_2153.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"1590_CR86","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10557-020-06968-0","volume":"34","author":"T Ni","year":"2020","unstructured":"Ni T, Lin N, Lu W, Sun Z, Lin H, Chi J, Guo H. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy. Cardiovasc Drugs Ther. 2020;34(3):291\u2013301. https:\/\/doi.org\/10.1007\/s10557-020-06968-0.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"1590_CR87","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.3390\/ijms24108604","volume":"24","author":"KL Pan","year":"2023","unstructured":"Pan KL, Hsu YC, Chang ST, Chung CM, Lin CL. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools. Int J Mol Sci. 2023;24(10):8604. https:\/\/doi.org\/10.3390\/ijms24108604.","journal-title":"Int J Mol Sci"},{"key":"1590_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fcvm.2019.00045","volume":"6","author":"TN Kambis","year":"2019","unstructured":"Kambis TN, Shahshahan HR, Kar S, Yadav SK, Mishra PK. Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy. Front Cardiovasc Med. 2019;6:45. https:\/\/doi.org\/10.3389\/fcvm.2019.00045.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"1590_CR89","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/cbin.11512","volume":"45","author":"XL Zhang","year":"2021","unstructured":"Zhang XL, Zhang G, Bai ZH. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1. Cell Biol Int. 2021;45(3):642\u201353. https:\/\/doi.org\/10.1002\/cbin.11512.","journal-title":"Cell Biol Int"},{"issue":"3","key":"1590_CR90","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/FJC.0000000000001","volume":"81","author":"K Wang","year":"2023","unstructured":"Wang K, Lin Y, Shen H, Yu S, Xu J. LncRNA TUG1 Exacerbates Myocardial Fibrosis in Diabetic Cardiomyopathy by Modulating the microRNA-145a-5p\/Cfl2 Axis. J Cardiovasc Pharmacol. 2023;81(3):192\u2013202. https:\/\/doi.org\/10.1097\/FJC.0000000000001.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1590_CR91","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00125-020-05353-8","volume":"64","author":"W Wang","year":"2021","unstructured":"Wang W, Zhang S, Xu L, Feng Y, Wu X, Zhang M, Yu Z, Zhou X. Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice. Diabetologia. 2021;64(3):681\u201392. https:\/\/doi.org\/10.1007\/s00125-020-05353-8.","journal-title":"Diabetologia"},{"issue":"11","key":"1590_CR92","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00592-021-01745-3","volume":"58","author":"C Zhu","year":"2021","unstructured":"Zhu C, Zhang H, Wei D, Sun Z. Silencing lncRNA GAS5 alleviates apoptosis and fibrosis in diabetic cardiomyopathy by targeting miR-26a\/b-5p. Acta Diabetol. 2021;58(11):1491\u2013501. https:\/\/doi.org\/10.1007\/s00592-021-01745-3.","journal-title":"Acta Diabetol"},{"issue":"15","key":"1590_CR93","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","volume":"71","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez A, Schelbert EB, D\u00edez J, Butler J. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. J Am Coll Cardiol. 2018;71(15):1696\u2013706. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.021.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1590_CR94","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cjca.2014.07.747","volume":"30","author":"S Liu","year":"2014","unstructured":"Liu S, Li W, Xu M, Huang H, Wang J, Chen X. Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts. Can J Cardiol. 2014;30(12):1689\u201399. https:\/\/doi.org\/10.1016\/j.cjca.2014.07.747.","journal-title":"Can J Cardiol."},{"issue":"3","key":"1590_CR95","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020;217(3):e20190103. https:\/\/doi.org\/10.1084\/jem.20190103.","journal-title":"J Exp Med"},{"issue":"10","key":"1590_CR96","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1111\/jcmm.16464","volume":"25","author":"L Dong","year":"2021","unstructured":"Dong L, Li JC, Hu ZJ, Huang XR, Wang L, Wang HL, Ma RCW, Lan HY, Yang SJ. Deletion of Smad3 protects against diabetic myocardiopathy in db\/db mice. J Cell Mol Med. 2021;25(10):4860\u20139. https:\/\/doi.org\/10.1111\/jcmm.16464.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"1590_CR97","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1002\/jcp.29386","volume":"235","author":"H Che","year":"2020","unstructured":"Che H, Wang Y, Li Y, Lv J, Li H, Liu Y, Dong R, Sun Y, Xu X, Zhao J, Wang L. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts. J Cell Physiol. 2020;235(11):7769\u201379. https:\/\/doi.org\/10.1002\/jcp.29386.","journal-title":"J Cell Physiol"},{"key":"1590_CR98","doi-asserted-by":"publisher","first-page":"709123","DOI":"10.3389\/fphys.2021.709123","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Yao J, Xie H, Wang C, Chen J, Wei K, Ji Y, Liu L. MicroRNA-195-5p Downregulation Inhibits Endothelial Mesenchymal Transition and Myocardial Fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and Inhibiting Transforming Growth Factor Beta 1-Smads-Snail Pathway. Front Physiol. 2021;12:709123. https:\/\/doi.org\/10.3389\/fphys.2021.709123.","journal-title":"Front Physiol"},{"key":"1590_CR99","doi-asserted-by":"publisher","first-page":"23010","DOI":"10.1038\/srep23010","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang JH, Zhang YY, Wang YZ, Wang J, Zhao Y, Jin XX, Xue GL, Li PH, Sun YL, Huang QH, Song XT, Zhang ZR, Gao X, Yang BF, Du ZM, Pan ZW. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGF\u03b21 and miR-29 pathways. Sci Rep. 2016;6:23010. https:\/\/doi.org\/10.1038\/srep23010.","journal-title":"Sci Rep"},{"issue":"2","key":"1590_CR100","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jacc.2018.09.089","volume":"73","author":"JC Kovacic","year":"2019","unstructured":"Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, Baker AH. Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(2):190\u2013209. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.089.","journal-title":"J Am Coll Cardiol"},{"key":"1590_CR101","doi-asserted-by":"publisher","first-page":"851941","DOI":"10.3389\/fendo.2022.851941","volume":"13","author":"M Wang","year":"2022","unstructured":"Wang M, Li Y, Li S, Lv J. Endothelial Dysfunction and Diabetic Cardiomyopathy. Front Endocrinol (Lausanne). 2022;13:851941. https:\/\/doi.org\/10.3389\/fendo.2022.851941.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1590_CR102","first-page":"1208","volume":"11","author":"GH Zhu","year":"2018","unstructured":"Zhu GH, Li R, Zeng Y, Zhou T, Xiong F, Zhu M. MicroRNA-142-3p inhibits high-glucose-induced endothelial-to-mesenchymal transition through targeting TGF-\u03b21\/Smad pathway in primary human aortic endothelial cells. Int J Clin Exp Pathol. 2018;11(3):1208\u201317.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1590_CR103","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2017.07.101","volume":"491","author":"H Geng","year":"2017","unstructured":"Geng H, Guan J. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway. Biochem Biophys Res Commun. 2017;491(2):329\u201336. https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.101.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1590_CR104","doi-asserted-by":"publisher","first-page":"768","DOI":"10.2337\/db15-1033","volume":"65","author":"B Feng","year":"2016","unstructured":"Feng B, Cao Y, Chen S, Chu X, Chu Y, Chakrabarti S. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy. Diabetes. 2016;65(3):768\u201379. https:\/\/doi.org\/10.2337\/db15-1033.","journal-title":"Diabetes"},{"key":"1590_CR105","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.lfs.2019.02.059","volume":"224","author":"C Liang","year":"2019","unstructured":"Liang C, Gao L, Liu Y, Liu Y, Yao R, Li Y, Xiao L, Wu L, Du B, Huang Z, Zhang Y. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart. Life Sci. 2019;224:12\u201322. https:\/\/doi.org\/10.1016\/j.lfs.2019.02.059.","journal-title":"Life Sci"},{"issue":"2","key":"1590_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199\u2013210. https:\/\/doi.org\/10.1002\/path.2277.","journal-title":"J Pathol"},{"issue":"3","key":"1590_CR107","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/jb\/mvab047","volume":"170","author":"X Liu","year":"2021","unstructured":"Liu X, Guo B, Zhang W, Ma B, Li Y. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK\/NF-\u03baB signalling pathway. J Biochem. 2021;170(3):349\u201362. https:\/\/doi.org\/10.1093\/jb\/mvab047.","journal-title":"J Biochem"},{"key":"1590_CR108","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.yjmcc.2017.03.002","volume":"105","author":"B Feng","year":"2017","unstructured":"Feng B, Chen S, Gordon AD, Chakrabarti S. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes. J Mol Cell Cardiol. 2017;105:70\u20136. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.03.002.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"1590_CR109","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3892\/mmr.2020.11495","volume":"22","author":"Y Li","year":"2020","unstructured":"Li Y, Duan JZ, He Q, Wang CQ. miR-155 modulates high glucose-induced cardiac fibrosis via the Nrf2\/HO-1 signaling pathway. Mol Med Rep. 2020;22(5):4003\u201316. https:\/\/doi.org\/10.3892\/mmr.2020.11495.","journal-title":"Mol Med Rep"},{"key":"1590_CR110","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.omtn.2022.07.007","volume":"29","author":"N Ghosh","year":"2022","unstructured":"Ghosh N, Fenton S, van Hout I, Jones GT, Coffey S, Williams MJA, Sugunesegran R, Parry D, Davis P, Schwenke DO, Chatterjee A, Katare R. Therapeutic knockdown of miR-320 improves deteriorated cardiac function in a pre-clinical model of non-ischemic diabetic heart disease. Mol Ther Nucleic Acids. 2022;29:330\u201342. https:\/\/doi.org\/10.1016\/j.omtn.2022.07.007.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"1590_CR111","doi-asserted-by":"publisher","first-page":"112464","DOI":"10.1016\/j.yexcr.2020.112464","volume":"399","author":"P Shi","year":"2021","unstructured":"Shi P, Zhao XD, Shi KH, Ding XS, Tao H. MiR-21-3p triggers cardiac fibroblasts pyroptosis in diabetic cardiac fibrosis via inhibiting androgen receptor. Exp Cell Res. 2021;399(2):112464. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112464.","journal-title":"Exp Cell Res"},{"key":"1590_CR112","doi-asserted-by":"publisher","first-page":"806966","DOI":"10.3389\/fmolb.2022.806966","volume":"9","author":"L Ren","year":"2022","unstructured":"Ren L, Chen X, Nie B, Qu H, Ju J, Bai Y. Ranolazine Inhibits Pyroptosis via Regulation of miR-135b in the Treatment of Diabetic Cardiac Fibrosis. Front Mol Biosci. 2022;9:806966. https:\/\/doi.org\/10.3389\/fmolb.2022.806966.","journal-title":"Front Mol Biosci"},{"key":"1590_CR113","doi-asserted-by":"publisher","first-page":"143995","DOI":"10.1016\/j.gene.2019.143995","volume":"715","author":"X Yang","year":"2019","unstructured":"Yang X, Li X, Lin Q, Xu Q. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA. Gene. 2019;715:143995. https:\/\/doi.org\/10.1016\/j.gene.2019.143995.","journal-title":"Gene"},{"issue":"1","key":"1590_CR114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-019-0814-4","volume":"18","author":"S Rawal","year":"2019","unstructured":"Rawal S, Nagesh PT, Coffey S, Van Hout I, Galvin IF, Bunton RW, Davis P, Williams MJA, Katare R. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium. Cardiovasc Diabetol. 2019;18(1):13. https:\/\/doi.org\/10.1186\/s12933-019-0814-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1590_CR115","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","volume":"17","author":"B Dai","year":"2018","unstructured":"Dai B, Li H, Fan J, Zhao Y, Yin Z, Nie X, Wang DW, Chen C. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Cardiovasc Diabetol. 2018;17(1):123. https:\/\/doi.org\/10.1186\/s12933-018-0767-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"1590_CR116","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.bbadis.2018.07.019","volume":"1864","author":"L Gao","year":"2018","unstructured":"Gao L, Liu Y, Guo S, Xiao L, Wu L, Wang Z, Liang C, Yao R, Zhang Y. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21\/PPARa signaling. Biochim Biophys Acta Mol Basis Dis. 2018;1864(10):3322\u201338. https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.019.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"1590_CR117","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1755-5922.12113","volume":"33","author":"SK Raut","year":"2015","unstructured":"Raut SK, Kumar A, Singh GB, Nahar U, Sharma V, Mittal A, Sharma R, Khullar M. miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy. Cardiovasc Ther. 2015;33(3):89\u201397. https:\/\/doi.org\/10.1111\/1755-5922.12113.","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"1590_CR118","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/dmrr.1054","volume":"26","author":"B Feng","year":"2010","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev. 2010;26(1):40\u20139. https:\/\/doi.org\/10.1002\/dmrr.1054.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1\u20132","key":"1590_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-016-2838-3","volume":"424","author":"GB Singh","year":"2017","unstructured":"Singh GB, Raut SK, Khanna S, Kumar A, Sharma S, Prasad R, Khullar M. MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy. Mol Cell Biochem. 2017;424(1\u20132):1\u201311. https:\/\/doi.org\/10.1007\/s11010-016-2838-3.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"1590_CR120","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajpath.2011.04.034","volume":"179","author":"E Shen","year":"2011","unstructured":"Shen E, Diao X, Wang X, Chen R, Hu B. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am J Pathol. 2011;179(2):639\u201350. https:\/\/doi.org\/10.1016\/j.ajpath.2011.04.034.","journal-title":"Am J Pathol"},{"issue":"6","key":"1590_CR121","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10741-023-10342-1","volume":"28","author":"N Kim","year":"2023","unstructured":"Kim N, Chung WY, Cho JY. The role and medical prospects of long non-coding RNAs in cardiovascular disease. Heart Fail Rev. 2023;28(6):1437\u201353. https:\/\/doi.org\/10.1007\/s10741-023-10342-1.","journal-title":"Heart Fail Rev"},{"key":"1590_CR122","doi-asserted-by":"publisher","first-page":"142191","DOI":"10.1016\/j.scitotenv.2020.142191","volume":"766","author":"C Wang","year":"2021","unstructured":"Wang C, Liu G, Yang H, Guo S, Wang H, Dong Z, Li X, Bai Y, Cheng Y. MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ. 2021;766:142191. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.142191.","journal-title":"Sci Total Environ"},{"issue":"9","key":"1590_CR123","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00592-021-01713-x","volume":"58","author":"SF Zhao","year":"2021","unstructured":"Zhao SF, Ye YX, Xu JD, He Y, Zhang DW, Xia ZY, Wang S. Long non-coding RNA KCNQ1OT1 increases the expression of PDCD4 by targeting miR-181a-5p, contributing to cardiomyocyte apoptosis in diabetic cardiomyopathy. Acta Diabetol. 2021;58(9):1251\u201367. https:\/\/doi.org\/10.1007\/s00592-021-01713-x.","journal-title":"Acta Diabetol"},{"key":"1590_CR124","doi-asserted-by":"publisher","unstructured":"Chen Y, Zhang Z, Zhu D, Zhao W, Li F. Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition. Biosci Rep. 2019;39(6):BSR20190444. https:\/\/doi.org\/10.1042\/BSR20190444.","DOI":"10.1042\/BSR20190444"},{"key":"1590_CR125","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fcell.2020.00243","volume":"8","author":"Y Qi","year":"2020","unstructured":"Qi Y, Wu H, Mai C, Lin H, Shen J, Zhang X, Gao Y, Mao Y, Xie X. LncRNA-MIAT-Mediated miR-214-3p Silencing Is Responsible for IL-17 Production and Cardiac Fibrosis in Diabetic Cardiomyopathy. Front Cell Dev Biol. 2020;8:243. https:\/\/doi.org\/10.3389\/fcell.2020.00243.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1590_CR126","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1096\/fj.201902692R","volume":"34","author":"H Che","year":"2020","unstructured":"Che H, Wang Y, Li H, Li Y, Sahil A, Lv J, Liu Y, Yang Z, Dong R, Xue H, Wang L. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1\/miR-141-mediated NLRP3 inflammasome and TGF-\u03b21\/Smads signaling in diabetic cardiomyopathy. FASEB J. 2020;34(4):5282\u201398. https:\/\/doi.org\/10.1096\/fj.201902692R.","journal-title":"FASEB J"},{"issue":"10","key":"1590_CR127","doi-asserted-by":"publisher","first-page":"e0276076","DOI":"10.1371\/journal.pone.0276076","volume":"17","author":"B Feng","year":"2022","unstructured":"Feng B, Liu J, Wang E, Su Z, Chakrabarti S. Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1. PLoS ONE. 2022;17(10):e0276076. https:\/\/doi.org\/10.1371\/journal.pone.0276076.","journal-title":"PLoS ONE"},{"issue":"6","key":"1590_CR128","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jcmg.2020.10.009","volume":"14","author":"R Pofi","year":"2021","unstructured":"Pofi R, Giannetta E, Galea N, Francone M, Campolo F, Barbagallo F, Gianfrilli D, Venneri MA, Filardi T, Cristini C, Antonini G, Badagliacca R, Frati G, Lenzi A, Carbone I, Isidori AM. Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix: A 5-Year Prospective Study. JACC Cardiovasc Imaging. 2021;14(6):1130\u201342. https:\/\/doi.org\/10.1016\/j.jcmg.2020.10.009.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1590_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijcard.2015.08.161","volume":"202","author":"S Rawal","year":"2016","unstructured":"Rawal S, Ram TP, Coffey S, Williams MJ, Saxena P, Bunton RW, Galvin IF, Katare R. Differential expression pattern of cardiovascular microRNAs in the human type-2 diabetic heart with normal ejection fraction. Int J Cardiol. 2016;202:40\u20133. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.161.","journal-title":"Int J Cardiol"},{"key":"1590_CR130","doi-asserted-by":"publisher","unstructured":"Abdul-Jabbar Ali S, Al-Shlah HH, Al-Hamdani MM, Al-Salihi OJ. Evaluating the Sensitivity of (miR-378) as a Circulatory Screening Biomarker for Diabetic Cardiomyopathy: Comparative Study. Medico-Legal Update. 2021; https:\/\/doi.org\/10.37506\/mlu.v21i1.2432.","DOI":"10.37506\/mlu.v21i1.2432"},{"issue":"4","key":"1590_CR131","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/biomedicines12040765","volume":"12","author":"E Radzioch","year":"2024","unstructured":"Radzioch E, D\u0105bek B, Balcerczyk-Lis M, et al. Diabetic Cardiomyopathy-From Basics through Diagnosis to Treatment. Biomedicines. 2024;12(4):765. https:\/\/doi.org\/10.3390\/biomedicines12040765.","journal-title":"Biomedicines"},{"issue":"2","key":"1590_CR132","doi-asserted-by":"publisher","first-page":"e1177","DOI":"10.1002\/prp2.1177","volume":"12","author":"Y Shou","year":"2024","unstructured":"Shou Y, Li X, Fang Q, et al. Progress in the treatment of diabetic cardiomyopathy, a systematic review. Pharmacol Res Perspect. 2024;12(2):e1177. https:\/\/doi.org\/10.1002\/prp2.1177.","journal-title":"Pharmacol Res Perspect"},{"issue":"49","key":"1590_CR133","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","volume":"43","author":"R Antoon","year":"2024","unstructured":"Antoon R, Overdevest N, Saleh AH, Keating A. Mesenchymal stromal cells as cancer promoters. Oncogene. 2024;43(49):3545\u201355. https:\/\/doi.org\/10.1038\/s41388-024-03183-1.","journal-title":"Oncogene"},{"key":"1590_CR134","doi-asserted-by":"publisher","first-page":"122761","DOI":"10.1016\/j.lfs.2024.122761","volume":"351","author":"A Kostecka","year":"2024","unstructured":"Kostecka A, Kalamon N, Skoniecka A, et al. Adipose-derived mesenchymal stromal cells in clinical trials: Insights from single-cell studies. Life Sci. 2024;351:122761. https:\/\/doi.org\/10.1016\/j.lfs.2024.122761.","journal-title":"Life Sci"},{"issue":"2","key":"1590_CR135","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","volume":"104","author":"S Barr\u00e8re-Lemaire","year":"2024","unstructured":"Barr\u00e8re-Lemaire S, Vincent A, Jorgensen C, Piot C, Nargeot J, Djouad F. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing. Physiol Rev. 2024;104(2):659\u2013725. https:\/\/doi.org\/10.1152\/physrev.00009.2023.","journal-title":"Physiol Rev"},{"issue":"1","key":"1590_CR136","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jcb.27531","volume":"120","author":"S Dolati","year":"2019","unstructured":"Dolati S, Yousefi M, Mahdipour M, et al. Mesenchymal stem cell and bone marrow mononuclear cell therapy for cardiomyopathy: From bench to bedside. J Cell Biochem. 2019;120(1):45\u201355. https:\/\/doi.org\/10.1002\/jcb.27531.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1590_CR137","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13098-024-01389-7","volume":"16","author":"Q Yang","year":"2024","unstructured":"Yang Q, Chen Q, Li S, Luo J. Mesenchymal stem cells ameliorate inflammation and pyroptosis in diabetic cardiomyopathy via the miRNA-223-3p\/NLRP3 pathway. Diabetol Metab Syndr. 2024;16(1):146. https:\/\/doi.org\/10.1186\/s13098-024-01389-7.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1590_CR138","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-024-03715-2","volume":"15","author":"B Liu","year":"2024","unstructured":"Liu B, Wei Y, He J, et al. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy. Stem Cell Res Ther. 2024;15(1):120. https:\/\/doi.org\/10.1186\/s13287-024-03715-2.","journal-title":"Stem Cell Res Ther"},{"key":"1590_CR139","doi-asserted-by":"publisher","first-page":"36340","DOI":"10.1038\/srep36340","volume":"6","author":"X Li","year":"2016","unstructured":"Li X, Wang H, Yao B, Xu W, Chen J, Zhou X. lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy. Sci Rep. 2016;6:36340. https:\/\/doi.org\/10.1038\/srep36340.","journal-title":"Sci Rep"},{"issue":"7","key":"1590_CR140","doi-asserted-by":"publisher","first-page":"e2929","DOI":"10.1038\/cddis.2017.321","volume":"8","author":"X Zhou","year":"2017","unstructured":"Zhou X, Zhang W, Jin M, Chen J, Xu W, Kong X. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death Dis. 2017;8(7):e2929. https:\/\/doi.org\/10.1038\/cddis.2017.321.","journal-title":"Cell Death Dis"},{"issue":"21","key":"1590_CR141","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.26355\/eurrev_202011_23615","volume":"24","author":"Y Han","year":"2020","unstructured":"Han Y, Tian H, Gao X. NORAD regulates proliferation and apoptosis in cardiomyocytes under high-glucose treatment through miRNA-150-5p\/ZEB1 axis. Eur Rev Med Pharmacol Sci. 2020;24(21):11259\u201365. https:\/\/doi.org\/10.26355\/eurrev_202011_23615.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1590_CR142","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1538\/expanim.19-0058","volume":"69","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Li J, Wang C, Yang H, Wang Y, Zhan T, Guo S, Liang J, Bai Y, Yu J, Liu G. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p. Exp Anim. 2020;69(1):34\u201344. https:\/\/doi.org\/10.1538\/expanim.19-0058.","journal-title":"Exp Anim"},{"key":"1590_CR143","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.biochi.2019.05.005","volume":"165","author":"G Zou","year":"2019","unstructured":"Zou G, Zhong W, Wu F, Wang X, Liu L. Catalpol attenuates cardiomyocyte apoptosis in diabetic cardiomyopathy via Neat1\/miR-140-5p\/HDAC4 axis. Biochimie. 2019;165:90\u20139. https:\/\/doi.org\/10.1016\/j.biochi.2019.05.005.","journal-title":"Biochimie"},{"issue":"4","key":"1590_CR144","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jab.2018.02.005","volume":"16","author":"J Jiang","year":"2018","unstructured":"Jiang J, Liang G, Wu Z, Mo H, You Q, Wang Z, Wu K, Guo R. Naringenin alleviates high D-glucose-induced injuries through upregulation of microRNA-30d-5p level in human AC16 cardiac cells. J Appl Biomed. 2018;16(4):274\u201380. https:\/\/doi.org\/10.1016\/j.jab.2018.02.005.","journal-title":"J Appl Biomed"},{"key":"1590_CR145","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1002\/jcb.29630","volume":"121","author":"D Su","year":"2020","unstructured":"Su D, Ju Y, Han W, Yang Y, Wang F, Wang T, Tang J. Tcf3-activated lncRNA Gas5 regulates newborn mouse cardiomyocyte apoptosis in diabetic cardiomyopathy. J Cell Biochem. 2020;121:4337\u201346. https:\/\/doi.org\/10.1002\/jcb.29630.","journal-title":"J Cell Biochem"},{"issue":"7","key":"1590_CR146","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/ph15070821","volume":"15","author":"H Tang","year":"2022","unstructured":"Tang H, Zhong H, Liu W, Wang Y, Wang Y, Wang L, Tang S, Zhu H. Melatonin Alleviates Hyperglycemia-Induced Cardiomyocyte Apoptosis via Regulation of Long Non-Coding RNA H19\/miR-29c\/MAPK Axis in Diabetic Cardiomyopathy. Pharmaceuticals (Basel). 2022;15(7):821. https:\/\/doi.org\/10.3390\/ph15070821.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1590_CR147","doi-asserted-by":"publisher","unstructured":"Zhuo X, Bai K, Wang Y, Liu P, Xi W, She J, Liu J. Long-chain noncoding RNA-GAS5\/hsa-miR-138-5p attenuates high glucose-induced cardiomyocyte damage by targeting CYP11B2. Biosci Rep. 2021;41(9):BSR20202232. https:\/\/doi.org\/10.1042\/BSR20202232.","DOI":"10.1042\/BSR20202232"},{"issue":"10\u201312","key":"1590_CR148","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00011-021-01500-y","volume":"70","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhu Y, Liu S, Liu J, Li X. NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD\/miR-125a-3p\/Fyn. Inflamm Res. 2021;70(10\u201312):1113\u201327. https:\/\/doi.org\/10.1007\/s00011-021-01500-y.","journal-title":"Inflamm Res"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-025-01590-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-025-01590-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-025-01590-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:03:11Z","timestamp":1770336191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-025-01590-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1007\/s11892-025-01590-6","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"15 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"42"}}